Prostate Cancer International is
for 2011 by Great NonProfits
Perspective Confidentiality Disclosure Reliability Courtesy
It will likely be evident to most well-informed prostate cancer patients, support group leaders, and advocates that a man with low-risk, early stage prostate cancer (“favorable histology”) is potentially a good candidate for prostate cancer surgery.
Filed under: Diagnosis, Management, Treatment | Tagged: active surveillance, continence, outcome, quality of life, RALP, robot-assisted laparoscopic prostatectomy, sexual function | Leave a Comment »
There has been a lot of media noise about a poster presented at the Genitourinary Cancer Symposium. The poster supposedly suggests that it takes 1,600 robot-assisted procedures (RALP) to be really good at this form of surgery.
Filed under: Management, Treatment | Tagged: experience, RALP, robot-assisted laparoscopic prostatectomy, skill | 5 Comments »
A report from the University of California San Diego says that robot-assisted laparoscopic prostatectomy (RALP) appears to be a safe and effective treatment for localized prostate cancer in men who are HIV-positive but are taking highly active antiretroviral therapy (HAART) and have undetectable viral loads (< 50).
Filed under: Management, Treatment | Tagged: HIV, RALP, robot-assisted laparoscopic prostatectomy | Leave a Comment »
There has been much discussion of whether surgical outcomes following robot-assisted laparoscopic prostatectomy (RALP) are comparable to those observed after open surgery. The 5-year outcome data from the Vattikuti Urology Institute at Henry Ford Hospital in Detroit may help us to make such a determination.
Filed under: Management, Treatment | Tagged: localized, outcome, RALP, robot-assisted laparoscopic prostatectomy | 4 Comments »
Another article in this week’s New England Journal of Medicine addresses the rapid increase in the number of robot-assisted surgical procedures carried out in the US between 2005 and 2008.
Filed under: Uncategorized | Tagged: cost, RALP, robot-assisted laparoscopic prostatectomy | 6 Comments »
Today’s news reports include commentary on studies dealing with: Whether RALP outcomes are really comparable to those from RRP Surgical expertise, surgical caseload, and pelvic lymphadenectomy in treatment of intermediate- and high-risk prostate cancer Sexual function after first-line treatment with SBRT (CyberKnife) Distinguishing true biochemical recurrence from a PSA “bounce” after 125I-based prostate brachytherapy
Filed under: Management, Treatment | Tagged: bounce, CyberKnife, ED, failure brachytherapy, LRP, lymphadenextomy, outcomes, PSA, RALP, robot-assisted laparoscopic prostatectomy, SBRT, sexual function, stereotactic body radiotherapy | Leave a Comment »
Many readers may be interested in an article by Gina Kolata in Saturday’s New York Times on the rapid uptake of robot-assisted laparoscopic prostatectomy (RALP) for the first-line treatment prostate cancer.
Filed under: Uncategorized | Tagged: marketing, RALP, robot-assisted laparoscopic prostatectomy | Comments Off
In today’s (slightly belated) news reports, we comment on studies dealing with: A possible association between hypertension and later diagnosis of prostate cancer Appropriate selection of high-risk patients for RALP Optimization of the appropriate use of docetaxel + prednisone in treatment of CRPC
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: CRPC, docetaxel, high-risk patients, hypertension, prednisone, RALP, risk, robot-assisted laparoscopic prostatectomy | Leave a Comment »
Today’s news reports address: Daily fat intake and risk for prostate cancer Salvage RALP as a treatment for patients in biochemical relapse after first-line EBRT Phase II data on fenretinide as a possible treatment for HRPC
Filed under: Drugs in development, Management, Prevention, Risk, Treatment | Tagged: fat intake, fatty acids, fenretinide, MUFA, PUFA, RALP, robot-assisted laparoscopic prostatectomy, salvage, SFA | Leave a Comment »
There are three fairly significant news reports today dealing with the following issues: The relationship between a family history of prostate cancer and age at diagnosis The impact of RALP on selection of surgery as a first-line treatment option The management of ADT-related hot flashes
Filed under: Diagnosis, Management, Risk, Treatment | Tagged: family history, hot flashes, RALP, robot-assisted laparoscopic prostatectomy, Treatment | Leave a Comment »
A new review in BJU International — available in full on the Web through the UroToday web site — provides a detailed review of the currently available data on the use of robot-assisted laparoscopic prostatectomy (RALP) for the treatment of localized prostate cancer.
Filed under: Management, Treatment | Tagged: RALP, robot-assisted laparoscopic prostatectomy | 1 Comment »
There has long been discussion over whether a lack of tactile sensation affects the likelihood of positive surgical margins (PSMs) in patients undergoing robot-assisted laparoscopic prostatectomy (RALP). A new single-institution cohort offers data on PSM rates in that institution’s most current 500 cases — with a specific emphasis on patients with clinically high-risk disease.
Filed under: Management, Treatment | Tagged: positive surgical margin, PSM, RALP, robot-assisted laparoscopic prostatectomy | 4 Comments »
In today’s prostate cancer news reports we address: The role of RALP in men ≥ 70 years of age The development of the COMPARE prostate cancer registry The risk for mortality within 30 days of a TURP for men with a history of ADT for prostate cancer Micro-RNA 221 levels as a marker for metastatic [...]
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: 30 days, ADT, androgen deprivation therapy, micro-RNA 221, mortality, RALP, registry, robot-assisted laparoscopic prostatectomy, transurethral resection, TURP | Leave a Comment »
Today’s news reports deal with: A comparative, single institution study of RALP vs RRP Bone mineral density and osteoporosis in men treated with intermittent hormone therapy Transdermal testosterone therapy in men with castration-resistant prostate cancer In a separate report we have discussed the development of a pre-biopsy risk assessment nomogram that incorporates results from PCA3 [...]
Filed under: Management, Treatment | Tagged: BMD, bone mineral density, intermittent hormone therapy, osterporosis, RALP, retropubic radical prostatectomy, robot-assisted laparoscopic prostatectomy, RRP, testosterone therapy | Leave a Comment »
We have regularly addressed the “learning curve” for surgeons who adopt new methods to carry our radical prostatectomies. A recent publication from an Australian group provides specific and useful insight into “early” use of the da Vinci system to carry out robot-assisted laparoscopic prostatectomy (RALP).
Filed under: Management, Treatment | Tagged: learning curve, RALP, robot-assisted laparoscopic prostatectomy | 1 Comment »
Search for new and
ongoing trials on the
CTAG PCa web site